Vuk Jeremic - 31 May 2023 Form 4 Insider Report for Blue Water Biotech, Inc. (ONCO)

Reporting relationship: Director
Issuer ticker: ONCO
Reported as of: 31 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jun 2023, 21:11:50 UTC
Prior SEC filing: 09 Nov 2022
Next SEC filing: 02 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Erin Henderson, attorney-in-fact

Key filing fact

Vuk Jeremic filed Form 4 for Blue Water Biotech, Inc. (ONCO) on 01 Jun 2023.

Key facts

This page summarizes Vuk Jeremic's Form 4 filing for Blue Water Biotech, Inc. (ONCO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 Jun 2023, 21:11.

Change

Previous filing in this sequence was filed on 09 Nov 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BWV transaction

Common Stock

Award

Transaction value: $0
Shares: +6,360
Change %
Price: $0.000000
Shares after: 6,360
Date: 31 May 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on May 31, 2024 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date.